A. P. Haynes

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

Andy C. Rawstron, Ben Kennedy, Paul Evans et al. · Blood · 2001 · 266 citations · Full text

Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

Monica Else, Claire Dearden, Estella Matutes et al. · British Journal of Haematology · 2009 · 264 citations

Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefit.

I. Grant McQuaker, A Hunter, Simon Pacey et al. · Journal of Clinical Oncology · 1997 · 122 citations

Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM–CAMPATH conditioning: an effective regimen with low procedure‐related toxicity

Gavin Cull, A. P. Haynes, Jenny Byrne et al. · British Journal of Haematology · 2000 · 70 citations · Full text

Cell Therapy, Beam–campath Conditioning, Immunology +22

Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate‐dose cyclophosphamide

I. Grant McQuaker, A. P. Haynes, C Stainer et al. · British Journal of Haematology · 1997 · 59 citations · Full text

Progenitor Cells, Cell Therapy, Immunology +22